Biochemical and imaging markers in patients with thalassaemia

Biochemical and imaging markers in patients with thalassaemia

Beta-thalassaemia is a genetic disease with different clinical aspects, which can lead to heart failure with a multifactorial mechanism. Over the last years, growing interest has been reported for biomarkers that may help in the diagnosis, staging and prognosis of heart disease at an early stage, in...

Full description

Bibliographic Details
Main Authors: Maria Vlachou, Vasileios Kamperidis, George Giannakoulas, Theodoros Karamitsos, Efthymia Vlachaki, Haralambos Karvounis
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Hellenic Journal of Cardiology
Subjects:
beta-thalassaemia
biomarkers
heart failure
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966620300804
id doaj-4d5766db9c3a4f8b85463e1a6a85998e
record_format Article
spelling doaj-4d5766db9c3a4f8b85463e1a6a85998e2021-04-10T04:15:12ZengElsevierHellenic Journal of Cardiology1109-96662021-01-01621412Biochemical and imaging markers in patients with thalassaemiaMaria Vlachou0Vasileios Kamperidis1George Giannakoulas2Theodoros Karamitsos3Efthymia Vlachaki4Haralambos Karvounis51st Cardiology Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece1st Cardiology Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece; Corresponding author. Vasileios Kamperidis MD, MSc, PhD, FESC , 1st Cardiology Department, AHEPA Hospital, Stilponos Kyriakidi 1, 54621, Thessaloniki, Greece. Tel: +30 2310 994830, Fax: +30 2310 994830.1st Cardiology Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece1st Cardiology Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, GreeceThalassaemia Unit, Ippokratio University Hospital, Thessaloniki, Greece1st Cardiology Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, GreeceBeta-thalassaemia is a genetic disease with different clinical aspects, which can lead to heart failure with a multifactorial mechanism. Over the last years, growing interest has been reported for biomarkers that may help in the diagnosis, staging and prognosis of heart disease at an early stage, in patients with beta-thalassaemia. This review will highlight the current clinical value of cardiac biomarkers in patients with beta-thalassaemia and the ongoing research for a possible expanded future use.http://www.sciencedirect.com/science/article/pii/S1109966620300804beta-thalassaemiabiomarkersheart failure
collection DOAJ
language English
format Article
sources DOAJ
author Maria Vlachou
Vasileios Kamperidis
George Giannakoulas
Theodoros Karamitsos
Efthymia Vlachaki
Haralambos Karvounis
spellingShingle Maria Vlachou
Vasileios Kamperidis
George Giannakoulas
Theodoros Karamitsos
Efthymia Vlachaki
Haralambos Karvounis
Biochemical and imaging markers in patients with thalassaemia
Hellenic Journal of Cardiology
beta-thalassaemia
biomarkers
heart failure
author_facet Maria Vlachou
Vasileios Kamperidis
George Giannakoulas
Theodoros Karamitsos
Efthymia Vlachaki
Haralambos Karvounis
author_sort Maria Vlachou
title Biochemical and imaging markers in patients with thalassaemia
title_short Biochemical and imaging markers in patients with thalassaemia
title_full Biochemical and imaging markers in patients with thalassaemia
title_fullStr Biochemical and imaging markers in patients with thalassaemia
title_full_unstemmed Biochemical and imaging markers in patients with thalassaemia
title_sort biochemical and imaging markers in patients with thalassaemia
publisher Elsevier
series Hellenic Journal of Cardiology
issn 1109-9666
publishDate 2021-01-01
description Beta-thalassaemia is a genetic disease with different clinical aspects, which can lead to heart failure with a multifactorial mechanism. Over the last years, growing interest has been reported for biomarkers that may help in the diagnosis, staging and prognosis of heart disease at an early stage, in patients with beta-thalassaemia. This review will highlight the current clinical value of cardiac biomarkers in patients with beta-thalassaemia and the ongoing research for a possible expanded future use.
topic beta-thalassaemia
biomarkers
heart failure
url http://www.sciencedirect.com/science/article/pii/S1109966620300804
work_keys_str_mv AT mariavlachou biochemicalandimagingmarkersinpatientswiththalassaemia
AT vasileioskamperidis biochemicalandimagingmarkersinpatientswiththalassaemia
AT georgegiannakoulas biochemicalandimagingmarkersinpatientswiththalassaemia
AT theodoroskaramitsos biochemicalandimagingmarkersinpatientswiththalassaemia
AT efthymiavlachaki biochemicalandimagingmarkersinpatientswiththalassaemia
AT haralamboskarvounis biochemicalandimagingmarkersinpatientswiththalassaemia
_version_ 1721531999474155520

Similar Items